MedTrace Logo

The Effects of tDCS on Auditory Hallucination, Insight, Neurocognitive Function and HRV in Patients With Schizophrenia

NCT03388554 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2018-05-01

No results posted yet for this study

Summary

The study aimed to investigate whether transcranial direct current stimulation could modify auditory hallucination, insight, neurocognitive function, heart rate variability, psychosocial functioning and quality of life in patients with schizophrenia.

Conditions

  • Schizophrenia
  • Schizoaffective Disorder
  • Auditory Hallucination, Verbal
  • Neurocognitive Dysfunction
  • Autonomic Imbalance
  • Psychosocial Impairment
  • Quality of Life

Interventions

DEVICE

tDCS

Sponsors & Collaborators

  • Tri-Service General Hospital

    lead OTHER

Principal Investigators

  • Hsin-An Chang, M.D. · Tri-Service General Hospital, National Defense Medical Center

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-07-31
Primary Completion
2018-03-02
Completion
2018-03-02

Countries

  • Taiwan

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03388554 on ClinicalTrials.gov